SCHEMBL6834585

SCHEMBL6834585

N#Cc1ccc(NC(=O)c2nnc(SCc3ccccc3)s2)c(C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
TSHR P16473 2/20 0.47
HPGD P15428 3/20 0.46
ABL1 P00519 3/20 0.45
SRC P12931 3/20 0.45
ALDH1A1 P00352 6/20 0.44
KDM4E B2RXH2 5/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
GAA P10253 3/20 0.44
PPARG P37231 1/20 0.44
PPP1CA P62136 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NR2E3 Q9Y5X4 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833355 0.86 ABL1 (0.50) LMNAHPGDABL1SRCALDH1A1
SCHEMBL6919473 0.83 ALB (0.45) LMNATSHRHPGDABL1SRC
SCHEMBL6835684 0.83 ALB (0.42) LMNATSHRABL1SRCALDH1A1
SCHEMBL6835621 0.77 SCD (0.42) LMNAHPGDALDH1A1KDM4EKMT2A
SCHEMBL6351822 0.77 SIRT2 (0.59) LMNAHPGDALDH1A1KDM4EMEN1
SCHEMBL6818018 0.77 ALB (0.49) KDM4EKMT2AALB
SCHEMBL6818090 0.77 ALB (0.65) HPGDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6835560 0.76 ALB (0.45) ALDH1A1KDM4EKMT2ATDP1SMN1; SMN2
Hydrochloric Acid SCHEMBL6833139 0.76 ALB (0.64) HPGDALDH1A1KDM4EMEN1KMT2A
SCHEMBL6833895 0.75 SMN1; SMN2 (0.55) LMNATSHRHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 LMNA 3376/4885TSHR 3622/4885HPGD 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.